Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 2
1966 3
1967 6
1968 1
1969 7
1970 6
1971 8
1972 6
1973 2
1974 3
1975 18
1976 14
1977 4
1978 8
1979 7
1980 6
1981 6
1982 4
1983 9
1984 8
1985 10
1986 11
1987 8
1988 9
1989 10
1990 10
1991 7
1992 14
1993 13
1994 17
1995 13
1996 13
1997 17
1998 9
1999 15
2000 6
2001 5
2002 11
2003 2
2004 8
2005 4
2006 3
2007 7
2008 14
2009 11
2010 8
2011 8
2012 9
2013 2
2014 1
2015 2
2016 7
2017 8
2018 6
2022 3
2023 2
2024 4
2025 2
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

431 results

Results by year

Filters applied: . Clear all
Page 1
Death Anxiety and Correlates in Cancer Patients Receiving Palliative Care.
Emanuel LL, Solomon S, Chochinov HM, Delgado Guay MO, Handzo G, Hauser J, Kittelson S, O'Mahony S, Quest TE, Rabow MW, Schoppee TM, Wilkie DJ, Yao Y, Fitchett G. Emanuel LL, et al. J Palliat Med. 2023 Feb;26(2):235-243. doi: 10.1089/jpm.2022.0052. Epub 2022 Sep 2. J Palliat Med. 2023. PMID: 36067074 Free PMC article. Clinical Trial.
Clinical trial of ofloxacin alone and in combination with dapsone plus clofazimine for treatment of lepromatous leprosy.
Ji B, Perani EG, Petinom C, N'Deli L, Grosset JH. Ji B, et al. Antimicrob Agents Chemother. 1994 Apr;38(4):662-7. doi: 10.1128/AAC.38.4.662. Antimicrob Agents Chemother. 1994. PMID: 8031029 Free PMC article. Clinical Trial.
Twenty-four patients with newly diagnosed lepromatous leprosy were allocated randomly to three groups and treated for 56 days with 400 mg of ofloxacin daily, 800 mg of ofloxacin daily, or 400 mg of ofloxacin, 100 mg of dapsone, and 50 mg of clofazimine daily plus 300 mg of …
Twenty-four patients with newly diagnosed lepromatous leprosy were allocated randomly to three groups and treated for 56 days with 400 mg of …
Efficacy and safety of dapsone in adult primary immune thrombocytopenia.
Larue M, Moulis G, Rueter M, Audia S, Comont T, Terriou L, Viallard JF, Pan-Petesch B, Royer B, Bonnotte B, Galicier L, Lambotte O, Lefrere F, Cheze S, Ebbo M, Duong TA, Boutin E, Languille L, Mahevas M, Godeau B, Canoui-Poitrine F, Michel M. Larue M, et al. Blood Adv. 2025 Apr 22;9(8):1976-1983. doi: 10.1182/bloodadvances.2024014939. Blood Adv. 2025. PMID: 39874521 Free PMC article. Clinical Trial.
Patients in the RCT were randomized in arm A (prednisone 3 weeks + dapsone for 12 months) or arm B (prednisone alone). The observational study involved dapsone initiation at 100 mg/d with standard follow-up. ...Adverse events occurred in 30.4%, leading to disconti …
Patients in the RCT were randomized in arm A (prednisone 3 weeks + dapsone for 12 months) or arm B (prednisone alone). The observat …
Adjuvant therapy of pemphigus.
Bystryn JC. Bystryn JC. Arch Dermatol. 1984 Jul;120(7):941-51. Arch Dermatol. 1984. PMID: 6375579 Review.
Chlorproguanil-dapsone versus sulfadoxine-pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: a randomised clinical trial.
Sulo J, Chimpeni P, Hatcher J, Kublin JG, Plowe CV, Molyneux ME, Marsh K, Taylor TE, Watkins WM, Winstanley PA. Sulo J, et al. Lancet. 2002 Oct 12;360(9340):1136-43. doi: 10.1016/s0140-6736(02)11198-6. Lancet. 2002. PMID: 12387962 Clinical Trial.
We aimed to find out whether chlorproguanil-dapsone results in a higher retreatment rate for malaria than sulfadoxine-pyrimethamine. ...Cause of anaemia in Kenya was probably not adverse reaction to chlorproguanil-dapsone, but this observation requires further study …
We aimed to find out whether chlorproguanil-dapsone results in a higher retreatment rate for malaria than sulfadoxine-pyrimethamine. …
A randomized clinical trial comparing safety, clinical and parasitological response to artemether-lumefantrine and chlorproguanil-dapsone in treatment of uncomplicated malaria in pregnancy in Mulago hospital, Uganda.
Kaye DK, Nshemerirwe R, Mutyaba TS, Ndeezi G. Kaye DK, et al. J Infect Dev Ctries. 2008 Apr 1;2(2):135-9. J Infect Dev Ctries. 2008. PMID: 19738339 Free article. Clinical Trial.
Participants were randomized to receive either Artemether-Lumefantrine (Coartem 20 mg/120 mg) orally or Chlorproguanil-Dapsone (Lapdap) orally for 3 consecutive days. Primary endpoints were clinical and parasitological response assessed on days 0, 1, 2, 4, 7, 14 and 28. .. …
Participants were randomized to receive either Artemether-Lumefantrine (Coartem 20 mg/120 mg) orally or Chlorproguanil-Dapsone (Lapda …
Neuroprotective effect of dapsone in patients with aneurysmal subarachnoid hemorrhage: a prospective, randomized, double-blind, placebo-controlled clinical trial.
García-Pastor C, Navarro-Garcia de Llano JP, Balcázar-Padrón JC, Tristán-López L, Rios C, Díaz-Ruíz A, Rodríguez-Hernandez LA, Nathal E. García-Pastor C, et al. Neurosurg Focus. 2022 Mar;52(3):E12. doi: 10.3171/2021.12.FOCUS21663. Neurosurg Focus. 2022. PMID: 35231887 Clinical Trial.
The incidence of DCI, the primary endpoint, for the whole cohort was 43.8% and was significantly lower in the dapsone group (26.9% vs 63.6%, p = 0.011). In addition, the irreversible DCI incidence was lower in the dapsone group (11.5% vs 54.5%, p = 0.12). ...CONCLUS …
The incidence of DCI, the primary endpoint, for the whole cohort was 43.8% and was significantly lower in the dapsone group (26.9% vs …
Clinical trial of pefloxacin and ofloxacin in the treatment of lepromatous leprosy.
Grosset JH, Ji BH, Guelpa-Lauras CC, Perani EG, N'Deli LN. Grosset JH, et al. Int J Lepr Other Mycobact Dis. 1990 Jun;58(2):281-95. Int J Lepr Other Mycobact Dis. 1990. PMID: 2198315 Clinical Trial.
Among the remaining 17 cases, four (23.5%) had primary resistance to dapsone but all of them were susceptible to rifampin. The initial (day 0) proportion of viable organisms, as measured by mouse foot pad inoculation, varied tremendously from patient to patient despite ran …
Among the remaining 17 cases, four (23.5%) had primary resistance to dapsone but all of them were susceptible to rifampin. The initia …
A clinical trial of ethionamide and prothionamide for treatment of lepromatous leprosy.
Fajardo TT, Guinto RS, Cellona RV, Abalos RM, Dela Cruz EC, Gelber RH. Fajardo TT, et al. Am J Trop Med Hyg. 2006 Mar;74(3):457-61. Am J Trop Med Hyg. 2006. PMID: 16525107 Clinical Trial.
Overall killing of M. leprae in this study was found to be similar to that obtained previously with dapsone and clofazimine, but less than was obtained with rifampin, minocycline, clarithromycin, pefloxacin, and ofloxacin....
Overall killing of M. leprae in this study was found to be similar to that obtained previously with dapsone and clofazimine, but less …
Randomized trial of safety and effectiveness of chlorproguanil-dapsone and lumefantrine-artemether for uncomplicated malaria in children in the Gambia.
Dunyo S, Sirugo G, Sesay S, Bisseye C, Njie F, Adiamoh M, Nwakanma D, Diatta M, Janha R, Sisay Joof F, Temple B, Snell P, Conway D, Walton R, Cheung YB, Milligan P. Dunyo S, et al. PLoS One. 2011;6(6):e17371. doi: 10.1371/journal.pone.0017371. Epub 2011 Jun 7. PLoS One. 2011. PMID: 21666744 Free PMC article. Clinical Trial.
BACKGROUND: Chlorproguanil-dapsone (Lapdap), developed as a low-cost antimalarial, was withdrawn in 2008 after concerns about safety in G6PD deficient patients. ...
BACKGROUND: Chlorproguanil-dapsone (Lapdap), developed as a low-cost antimalarial, was withdrawn in 2008 after concerns about safety …
431 results